C.R. Bard Company Profile (NYSE:BCR)

About C.R. Bard (NYSE:BCR)

C.R. Bard logoC. R. Bard, Inc. (Bard) is engaged in designing, manufacturing, packaging, distribution and sale of medical, surgical, diagnostic and patient care devices. The Company operates through the manufacture and sale of medical devices segment. It sells a range of products to hospitals, individual healthcare professionals, extended care facilities and alternate site facilities on a global basis. Its vascular products cover a range of minimally invasive devices for the treatment of peripheral vascular disease and end-stage renal disease. Its urology products include basic urology drainage products, fecal and urinary continence products, urological specialty products and Targeted Temperature Management products. Its oncology products cover a range of devices used in the treatment and management of various cancers, and other diseases and disorders. Its surgical specialty products include implanted patches and fixation devices for hernia and soft tissue repairs.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Equipment, Supplies & Distribution
  • Sub-Industry: Health Care Equipment
  • Symbol: NYSE:BCR
  • CUSIP: 06738310
  • Web: www.crbard.com
  • Market Cap: $23.99 billion
  • Outstanding Shares: 72,671,000
Average Prices:
  • 50 Day Moving Avg: $321.38
  • 200 Day Moving Avg: $310.37
  • 52 Week Range: $203.63 - $330.16
  • Trailing P/E Ratio: 43.35
  • Foreward P/E Ratio: 25.46
  • P/E Growth: 2.35
Sales & Book Value:
  • Annual Revenue: $3.83 billion
  • Price / Sales: 6.26
  • Book Value: $25.52 per share
  • Price / Book: 12.94
  • Annual Dividend: $1.04
  • Dividend Yield: 0.3%
  • EBITDA: $1.18 billion
  • Net Margins: 14.99%
  • Return on Equity: 48.70%
  • Return on Assets: 15.89%
  • Debt-to-Equity Ratio: 0.62%
  • Current Ratio: 1.58%
  • Quick Ratio: 1.24%
  • Average Volume: 447,272 shs.
  • Beta: 0.58
  • Short Ratio: 0.91

Frequently Asked Questions for C.R. Bard (NYSE:BCR)

What is C.R. Bard's stock symbol?

C.R. Bard trades on the New York Stock Exchange (NYSE) under the ticker symbol "BCR."

How often does C.R. Bard pay dividends? What is the dividend yield for C.R. Bard?

C.R. Bard declared a quarterly dividend on Wednesday, October 11th. Shareholders of record on Friday, December 8th will be paid a dividend of $0.26 per share on Friday, December 29th. This represents a $1.04 annualized dividend and a yield of 0.31%. The ex-dividend date of this dividend is Thursday, December 7th. View C.R. Bard's Dividend History.

How were C.R. Bard's earnings last quarter?

C.R. Bard, Inc. (NYSE:BCR) posted its quarterly earnings results on Thursday, July, 27th. The company reported $2.92 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $2.84 by $0.08. The company had revenue of $979.70 million for the quarter, compared to analyst estimates of $976.53 million. C.R. Bard had a net margin of 14.99% and a return on equity of 48.70%. The business's revenue for the quarter was up 5.2% on a year-over-year basis. During the same period in the previous year, the company earned $2.54 earnings per share. View C.R. Bard's Earnings History.

What guidance has C.R. Bard issued on next quarter's earnings?

C.R. Bard updated its FY17 earnings guidance on Thursday, July, 27th. The company provided earnings per share guidance of $11.70-$11.90 for the period, compared to the Thomson Reuters consensus estimate of $11.81.

Where is C.R. Bard's stock going? Where will C.R. Bard's stock price be in 2017?

7 brokerages have issued 1 year target prices for C.R. Bard's shares. Their forecasts range from $245.00 to $317.00. On average, they anticipate C.R. Bard's stock price to reach $282.29 in the next year. View Analyst Ratings for C.R. Bard.

What are analysts saying about C.R. Bard stock?

Here are some recent quotes from research analysts about C.R. Bard stock:

  • 1. According to Zacks Investment Research, "Over the past one year, C. R. Bard has outperformed the broader industry trends with respect to price performance. The company exhibited a solid second quarter of 2017, beating the Zacks Consensus on both lines. Looking forward C. R. Bard is expected to benefit from the impending merger with Becton, Dickinson and Company, especially in the areas of medication management and infection prevention. The $24 billion transaction is expected to close in the fourth quarter of 2017. We believe the development will provide benefits to the combined entity and bolster its foothold in the global medical devices market. The growing adoption of Lutonix DCB is also expected to drive top-line growth in the coming quarters.However, a challenging Med-tech environment is a major concern. The company witnesses significant pricing pressure as well. Additionally, cutthroat competition in the hernia fixation and peripheral stent businesses are likely to dent growth." (8/1/2017)
  • 2. Needham & Company LLC analysts commented, "BCR’s 4Q16 revenue and EPS beat consensus and management provided initial 2017 revenue guidance that was in line with consensus and EPS guidance that was above consensus. Organic revenue growth improved to 6.9% in 4Q16 from 6.4% in 3Q16. Although BCR’s gross margin declined slightly, its operating margin improved by 150 bps Y/Y due to significant SG&A leverage." (1/27/2017)

Who are some of C.R. Bard's key competitors?

Who are C.R. Bard's key executives?

C.R. Bard's management team includes the folowing people:

  • Timothy M. Ring, Chairman of the Board, Chief Executive Officer
  • John H. Weiland, President, Vice Chairman of the Board, Chief Operating Officer
  • James C. Beasley, Group President
  • Timothy P. Collins, Group President
  • John P. Groetelaars, Group President
  • Christopher S. Holland, Chief Financial Officer, Senior Vice President
  • Samrat S. Khichi, Senior Vice President, General Counsel, Secretary
  • John A. DeFord Ph.D., Senior Vice President - Science, Technology and Clinical Affairs
  • Frank Lupisella Jr., Vice President, Controller
  • Betty D. Larson, Vice President - Human Resources

Who owns C.R. Bard stock?

C.R. Bard's stock is owned by a variety of of institutional and retail investors. Top institutional investors include APG Asset Management N.V. (0.61%), Havens Advisors LLC (0.03%), State Treasurer State of Michigan (0.03%), Harvey Investment Co. LLC (0.02%), LS Investment Advisors LLC (0.02%) and Meeder Asset Management Inc. (0.01%). Company insiders that own C.R. Bard stock include Anthony Welters, Betty D Larson, Christopher S Holland, Frank Lupisella Jr, Frank Lupisella, Jr, Gail K Naughton, Jim C Beasley, John A Deford, John H Weiland, John P Groetelaars, Patricia G Christian, Sharon M Luboff, Timothy M Ring, Timothy P Collins, Tommy G Thompson and Tony L White. View Institutional Ownership Trends for C.R. Bard.

Who sold C.R. Bard stock? Who is selling C.R. Bard stock?

C.R. Bard's stock was sold by a variety of institutional investors in the last quarter, including APG Asset Management N.V., Robeco Institutional Asset Management B.V., State Treasurer State of Michigan, Meeder Asset Management Inc., Harvey Investment Co. LLC, LS Investment Advisors LLC, Park National Corp OH and Foster & Motley Inc.. Company insiders that have sold C.R. Bard stock in the last year include Betty D Larson, Christopher S Holland, Frank Lupisella Jr, Frank Lupisella, Jr, Gail K Naughton, Jim C Beasley, John A Deford, John H Weiland, John P Groetelaars, Sharon M Luboff, Timothy M Ring and Timothy P Collins. View Insider Buying and Selling for C.R. Bard.

Who bought C.R. Bard stock? Who is buying C.R. Bard stock?

C.R. Bard's stock was bought by a variety of institutional investors in the last quarter, including Havens Advisors LLC, Assenagon Asset Management S.A., Oakbrook Investments LLC and Curbstone Financial Management Corp. View Insider Buying and Selling for C.R. Bard.

How do I buy C.R. Bard stock?

Shares of C.R. Bard can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is C.R. Bard's stock price today?

One share of C.R. Bard stock can currently be purchased for approximately $330.16.

MarketBeat Community Rating for C.R. Bard (NYSE BCR)
Community Ranking:  1.8 out of 5 (star)
Outperform Votes:  254 (Vote Outperform)
Underperform Votes:  464 (Vote Underperform)
Total Votes:  718
MarketBeat's community ratings are surveys of what our community members think about C.R. Bard and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for C.R. Bard (NYSE:BCR) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 7 Hold Ratings
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $282.29 (14.50% downside)
Consensus Price Target History for C.R. Bard (NYSE:BCR)
Price Target History for C.R. Bard (NYSE:BCR)
Analysts' Ratings History for C.R. Bard (NYSE:BCR)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
9/14/2017Jefferies Group LLCReiterated RatingHold$317.00MediumView Rating Details
7/11/2017BMO Capital MarketsReiterated RatingHold$317.00LowView Rating Details
4/26/2017Raymond James Financial, Inc.DowngradeStrong-Buy -> Mkt PerformLowView Rating Details
4/25/2017Wells Fargo & CompanyDowngradeOutperform -> Market PerformLowView Rating Details
4/24/2017Morgan StanleyDowngradeOverweight -> Equal WeightLowView Rating Details
4/24/2017Cowen and CompanyBoost Price TargetMarket Perform$240.00 -> $317.00HighView Rating Details
1/29/2017Barclays PLCReiterated RatingHold$245.00N/AView Rating Details
1/27/2017Needham & Company LLCReiterated RatingHoldN/AView Rating Details
1/27/2017JMP SecuritiesBoost Price Target$240.00 -> $255.00N/AView Rating Details
9/15/2016Evercore ISIInitiated CoverageBuy$235.00N/AView Rating Details
7/28/2016Leerink SwannReiterated RatingMarket Perform$240.00 -> $233.00N/AView Rating Details
7/27/2016J P Morgan Chase & CoBoost Price TargetNeutral$214.00 -> $225.00N/AView Rating Details
7/27/2016Citigroup Inc.Boost Price TargetBuy$241.00 -> $265.00N/AView Rating Details
7/27/2016Deutsche Bank AGBoost Price TargetHold$234.00 -> $240.00N/AView Rating Details
7/8/2016Bank of America CorporationDowngradeBuy -> NeutralN/AView Rating Details
5/24/2016Piper Jaffray CompaniesReiterated RatingBuy$241.00N/AView Rating Details
3/17/2016NomuraInitiated CoverageNeutral$205.00N/AView Rating Details
1/29/2016Goldman Sachs Group, Inc. (The)Lower Price TargetBuy$214.00 -> $211.00N/AView Rating Details
10/23/2015Brean CapitalReiterated RatingHoldN/AView Rating Details
10/23/2015William BlairReiterated RatingHoldN/AView Rating Details
(Data available from 10/23/2015 forward)


Earnings History for C.R. Bard (NYSE:BCR)
Earnings by Quarter for C.R. Bard (NYSE:BCR)
Earnings History by Quarter for C.R. Bard (NYSE BCR)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
7/27/2017Q2 2017$2.84$2.92$976.53 million$979.70 millionViewN/AView Earnings Details
4/23/2017Q1 2017$2.65$2.87$916.15 million$938.80 millionViewN/AView Earnings Details
1/26/2017Q416$2.74$2.77$956.12 million$967.10 millionViewListenView Earnings Details
10/25/2016Q3$2.55$2.64$931.66 million$941.90 millionViewListenView Earnings Details
7/26/2016Q2$2.47$2.54$915.22 million$931.50 millionViewListenView Earnings Details
4/27/2016Q116$2.17$2.34$845.77 million$873.50 millionViewListenView Earnings Details
1/28/2016Q415$2.41$2.43$867.22 million$870.80 millionViewListenView Earnings Details
10/22/2015Q3$2.24$2.28$852.93 million$865.70 millionViewListenView Earnings Details
7/23/2015Q2$2.18$2.27$836.18 million$859.80 millionViewListenView Earnings Details
4/23/2015Q115$2.07$2.10$813.36 million$819.70 millionViewListenView Earnings Details
1/29/2015Q414$2.24$2.29$855.11 million$867.20 millionViewListenView Earnings Details
10/22/2014Q314$2.10$2.15$819.20 million$830.00 millionViewListenView Earnings Details
7/24/2014Q214$2.00$2.06$814.58 million$827.10 millionViewListenView Earnings Details
4/22/2014Q114$1.86$1.91$787.10 million$799.30 millionViewListenView Earnings Details
1/30/2014Q413$1.41$1.42$782.28 million$791.30 millionViewListenView Earnings Details
10/22/2013Q313$1.40$1.50$739.12 million$758.00 millionViewListenView Earnings Details
7/23/2013Q2 2013$1.38$1.42$750.91 million$759.90 millionViewListenView Earnings Details
4/23/2013Q1 2013$1.42$1.44$728.45 million$740.30 millionViewListenView Earnings Details
1/31/2013Q4 2012$1.67$1.70$757.49 million$762.60 millionViewListenView Earnings Details
10/23/2012$1.64$1.64ViewN/AView Earnings Details
7/25/2012$1.64$1.62ViewN/AView Earnings Details
1/31/2012$1.68$1.70ViewN/AView Earnings Details
10/25/2011$1.60$1.62ViewN/AView Earnings Details
7/21/2011$1.57$1.57ViewN/AView Earnings Details
4/21/2011$1.46$1.51ViewN/AView Earnings Details
1/31/2011$1.48$1.54ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for C.R. Bard (NYSE:BCR)
2017 EPS Consensus Estimate: $11.46
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20173$2.56$2.64$2.61
Q2 20173$2.80$2.82$2.81
Q3 20173$2.89$3.02$2.96
Q4 20173$2.99$3.15$3.09
Q1 20181$2.88$2.88$2.88
Q2 20181$3.12$3.12$3.12
Q3 20181$3.19$3.19$3.19
(Data provided by Zacks Investment Research)


Current Dividend Information for C.R. Bard (NYSE:BCR)
Next Dividend:12/29/2017
Annual Dividend:$1.04
Dividend Yield:0.31%
Dividend Growth:6.80% (3 Year Average)
Payout Ratio:13.67% (Trailing 12 Months of Earnings)
8.78% (Based on This Year's Estimates)
8.02% (Based on Next Year's Estimates)
Track Record:45 Years of Consecutive Dividend Growth
Dividend Payments by Quarter for C.R. Bard (NYSE:BCR)

Dividend History by Quarter for C.R. Bard (NYSE BCR)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for C.R. Bard (NYSE:BCR)
Insider Ownership Percentage: 0.80%
Institutional Ownership Percentage: 79.22%
Insider Trades by Quarter for C.R. Bard (NYSE:BCR)
Institutional Ownership by Quarter for C.R. Bard (NYSE:BCR)
Insider Trades by Quarter for C.R. Bard (NYSE:BCR)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/18/2017Frank Lupisella, Jr.VPSell9,173$325.00$2,981,225.00View SEC Filing  
10/12/2017Timothy P CollinsInsiderSell55,818$322.03$17,975,070.54View SEC Filing  
10/9/2017Timothy P CollinsInsiderSell8,388$322.00$2,700,936.00View SEC Filing  
9/29/2017Sharon M. LuboffInsiderSell30,252$320.00$9,680,640.00View SEC Filing  
8/10/2017John P GroetelaarsInsiderSell23,687$318.73$7,549,757.51View SEC Filing  
4/24/2017Frank Lupisella JrVPSell3,622$304.00$1,101,088.00View SEC Filing  
2/21/2017Jim C BeasleyInsiderSell4,390$245.00$1,075,550.00View SEC Filing  
2/14/2017John A DefordVPSell2,788$240.51$670,541.88View SEC Filing  
2/14/2017John H WeilandVice ChairmanSell14,091$240.49$3,388,744.59View SEC Filing  
2/14/2017John P GroetelaarsInsiderSell732$240.49$176,038.68View SEC Filing  
2/14/2017Timothy M RingChairmanSell14,425$240.50$3,469,212.50View SEC Filing  
2/13/2017John A. DefordVPSell469$240.07$112,592.83View SEC Filing  
2/13/2017John H WeilandVice ChairmanSell1,274$240.00$305,760.00View SEC Filing  
2/13/2017Timothy M RingChairmanSell1,767$240.02$424,115.34View SEC Filing  
2/13/2017Timothy P CollinsInsiderSell642$240.30$154,272.60View SEC Filing  
2/10/2017Betty D LarsonVPSell3,292$240.92$793,108.64View SEC Filing  
2/9/2017Jim C BeasleyInsiderSell8,593$239.58$2,058,710.94View SEC Filing  
2/9/2017John A. DefordVPSell5,816$239.58$1,393,397.28View SEC Filing  
2/9/2017John H WeilandVice ChairmanSell14,281$239.54$3,420,870.74View SEC Filing  
2/9/2017Timothy M RingChairmanSell20,324$239.56$4,868,817.44View SEC Filing  
1/31/2017Gail K NaughtonDirectorSell367$236.22$86,692.74View SEC Filing  
1/11/2017John P GroetelaarsInsiderSell573$235.00$134,655.00View SEC Filing  
1/10/2017Frank Lupisella, Jr.VPSell2,945$232.00$683,240.00View SEC Filing  
1/9/2017Frank Lupisella, Jr.VPSell210$232.00$48,720.00View SEC Filing  
12/30/2016Frank Lupisella JrVPSell237$226.00$53,562.00View SEC Filing  
12/30/2016Jim C BeasleyInsiderSell4,709$225.00$1,059,525.00View SEC Filing  
12/12/2016John A. DefordVPSell15,883$218.03$3,462,970.49View SEC Filing  
12/12/2016John H WeilandVice ChairmanSell11,190$219.67$2,458,107.30View SEC Filing  
12/12/2016Sharon M. LuboffInsiderSell6,000$219.00$1,314,000.00View SEC Filing  
10/28/2016Christopher S. HollandInsiderSell5,724$211.12$1,208,450.88View SEC Filing  
9/28/2016Timothy M RingChairmanSell92,293$227.81$21,025,268.33View SEC Filing  
9/26/2016Timothy M RingChairmanSell110,000$228.96$25,185,600.00View SEC Filing  
9/19/2016Betty D LarsonVPSell4,032$225.33$908,530.56View SEC Filing  
9/6/2016John A. DefordVPSell7,928$221.06$1,752,563.68View SEC Filing  
5/27/2016Christopher S HollandCFOSell3,970$219.89$872,963.30View SEC Filing  
5/17/2016John P GroetelaarsInsiderSell1,162$219.88$255,500.56View SEC Filing  
5/12/2016Tommy G ThompsonDirectorSell500$219.52$109,760.00View SEC Filing  
5/5/2016Tony L WhiteDirectorSell1,200$216.19$259,428.00View SEC Filing  
4/28/2016Jim C BeasleyInsiderSell4,709$215.00$1,012,435.00View SEC Filing  
4/27/2016Sharon M LuboffVPSell10,000$210.00$2,100,000.00View SEC Filing  
3/29/2016Christopher S HollandCFOSell1,650$200.00$330,000.00View SEC Filing  
2/25/2016Jim C BeasleyInsiderSell1,113$195.27$217,335.51View SEC Filing  
2/23/2016Frank Lupisella JrVPSell2,300$190.25$437,575.00View SEC Filing  
2/22/2016Christopher S HollandCFOSell618$190.00$117,420.00View SEC Filing  
2/22/2016Patricia G ChristianVPSell3,182$190.00$604,580.00View SEC Filing  
2/17/2016John A. DefordVPSell661$187.44$123,897.84View SEC Filing  
2/17/2016John H. WeilandCOOSell1,618$187.45$303,294.10View SEC Filing  
2/17/2016Timothy M. RingCEOSell2,453$187.62$460,231.86View SEC Filing  
2/17/2016Timothy P. CollinsinsiderSell974$187.48$182,605.52View SEC Filing  
2/16/2016Anthony WeltersDirectorSell1,784$187.47$334,446.48View SEC Filing  
2/12/2016Christopher S. HollandCFOSell6,297$181.08$1,140,260.76View SEC Filing  
2/12/2016John A. DefordVPSell6,400$182.40$1,167,360.00View SEC Filing  
2/12/2016John H. WeilandCOOSell15,632$182.86$2,858,467.52View SEC Filing  
2/12/2016Timothy M. RingCEOSell24,003$182.76$4,386,788.28View SEC Filing  
2/12/2016Timothy P. CollinsinsiderSell7,893$182.28$1,438,736.04View SEC Filing  
2/10/2016John P. GroetelaarsinsiderSell3,319$187.16$621,184.04View SEC Filing  
2/9/2016John A. DefordVPSell3,407$180.62$615,372.34View SEC Filing  
2/9/2016John H. WeilandCOOSell8,898$181.10$1,611,427.80View SEC Filing  
2/9/2016Timothy M. RingCEOSell4,836$181.20$876,283.20View SEC Filing  
2/9/2016Timothy P. CollinsinsiderSell4,205$181.24$762,114.20View SEC Filing  
2/2/2016Tommy G ThompsonDirectorSell2,319$188.75$437,711.25View SEC Filing  
12/16/2015John H. WeilandCOOSell19,686$188.49$3,710,614.14View SEC Filing  
12/16/2015Patricia G ChristianVPSell1,908$190.00$362,520.00View SEC Filing  
12/14/2015Jim C. BeasleyinsiderSell20,577$184.78$3,802,218.06View SEC Filing  
12/14/2015John A. DefordVPSell5,627$184.00$1,035,368.00View SEC Filing  
12/14/2015John H. WeilandCOOSell33,569$184.25$6,185,088.25View SEC Filing  
11/30/2015Timothy M. RingCEOSell22,052$187.37$4,131,883.24View SEC Filing  
10/29/2015Timothy M. RingCEOSell30,543$184.79$5,644,040.97View SEC Filing  
10/27/2015Gail K. NaughtonDirectorSell2,458$181.99$447,331.42View SEC Filing  
9/29/2015Timothy M. RingCEOSell40,000$185.16$7,406,400.00View SEC Filing  
8/31/2015Timothy M. RingCEOSell40,000$195.17$7,806,800.00View SEC Filing  
8/18/2015Sharon M. LuboffVPSell2,374$199.76$474,230.24View SEC Filing  
8/17/2015Sharon M LuboffVPSell2,030$200.00$406,000.00View SEC Filing  
8/14/2015Tommy G ThompsonDirectorSell1,200$199.25$239,100.00View SEC Filing  
7/13/2015John P GroetelaarsInsiderSell2,456$175.00$429,800.00View SEC Filing  
7/13/2015Timothy M RingCEOSell20,000$176.04$3,520,800.00View SEC Filing  
4/28/2015Tommy G ThompsonDirectorSell1,200$170.43$204,516.00View SEC Filing  
3/23/2015Timothy M RingCEOSell7,628$170.65$1,301,718.20View SEC Filing  
2/23/2015Timothy M RingCEOSell20,000$176.33$3,526,600.00View SEC Filing  
2/19/2015Jim C BeasleyInsiderSell2,884$174.79$504,094.36View SEC Filing  
2/19/2015John H WeilandCOOSell8,413$174.99$1,472,190.87View SEC Filing  
2/19/2015John P GroetelaarsVPSell4,566$175.14$799,689.24View SEC Filing  
2/17/2015Jim C BeasleyInsiderSell9,904$174.58$1,729,040.32View SEC Filing  
2/17/2015John A DefordVPSell6,146$174.58$1,072,968.68View SEC Filing  
2/17/2015John H WeilandCOOSell13,616$174.51$2,376,128.16View SEC Filing  
2/17/2015Timothy M RingCEOSell6,284$174.75$1,098,129.00View SEC Filing  
2/12/2015Patricia G ChristianVPSell1,408$173.97$244,949.76View SEC Filing  
2/12/2015Timothy M RingCEOSell14,363$173.74$2,495,427.62View SEC Filing  
2/12/2015Timothy P CollinsInsiderSell6,564$174.00$1,142,136.00View SEC Filing  
2/9/2015Anthony WeltersDirectorSell1,563$169.02$264,178.26View SEC Filing  
1/22/2015Timothy M RingCEOSell20,000$177.84$3,556,800.00View SEC Filing  
12/22/2014Timothy M RingCEOSell32,325$169.64$5,483,613.00View SEC Filing  
12/17/2014Jim C BeasleyInsiderSell4,525$168.42$762,100.50View SEC Filing  
12/17/2014Sharon M LuboffVPSell3,564$168.36$600,035.04View SEC Filing  
12/16/2014Jim C BeasleyInsiderSell14,634$167.47$2,450,755.98View SEC Filing  
12/16/2014John A DefordVPSell5,626$167.47$942,186.22View SEC Filing  
12/16/2014John H WeilandCOOSell23,093$166.74$3,850,526.82View SEC Filing  
12/16/2014Timothy M RingCEOSell15,232$166.60$2,537,651.20View SEC Filing  
12/15/2014John H WeilandCOOSell13,589$166.56$2,263,383.84View SEC Filing  
12/10/2014Patricia G ChristianVPSell1,269$169.20$214,714.80View SEC Filing  
12/9/2014John H WeilandCOOSell6,350$170.32$1,081,532.00View SEC Filing  
12/9/2014Timothy M RingCEOSell9,550$170.20$1,625,410.00View SEC Filing  
10/27/2014Sharon M LuboffVPSell10,000$158.80$1,588,000.00View SEC Filing  
10/22/2014Timothy M RingCEOSell60,000$149.07$8,944,200.00View SEC Filing  
10/6/2014Timothy M RingCEOSell60,000$148.00$8,880,000.00View SEC Filing  
9/10/2014John H WeilandCOOSell27,179$149.50$4,063,260.50View SEC Filing  
9/2/2014Timothy M RingCEOSell10,228$148.83$1,522,233.24View SEC Filing  
8/4/2014Bronwen K KellyVPSell10,055$150.25$1,510,763.75View SEC Filing  
8/1/2014Timothy M RingCEOSell10,231$149.04$1,524,828.24View SEC Filing  
7/30/2014Timothy P CollinsInsiderSell30,914$150.38$4,648,847.32View SEC Filing  
7/29/2014Sharon M LuboffVPSell5,115$151.37$774,257.55View SEC Filing  
7/1/2014Timothy M RingCEOSell10,231$144.30$1,476,333.30View SEC Filing  
6/2/2014Timothy M RingCEOSell10,231$147.50$1,509,072.50View SEC Filing  
3/3/2014Timothy RingCEOSell10,231$142.23$1,455,155.13View SEC Filing  
2/27/2014Sharon LuboffVPSell9,914$144.86$1,436,142.04View SEC Filing  
2/20/2014Frank Lupisella, Jr.VPSell2,520$140.26$353,455.20View SEC Filing  
2/18/2014Marc BreslawskyDirectorSell2,400$141.34$339,216.00View SEC Filing  
2/11/2014John WeilandCOOSell9,328$135.32$1,262,264.96View SEC Filing  
2/11/2014Sharon LuboffVPSell1,400$135.00$189,000.00View SEC Filing  
1/16/2014John WeilandCOOSell81,500$136.13$11,094,595.00View SEC Filing  
1/13/2014Sharon LuboffVPSell2,500$135.00$337,500.00View SEC Filing  
12/12/2013Jim BeasleyInsiderSell9,802$133.98$1,313,271.96View SEC Filing  
12/12/2013John DefordVPSell2,792$133.98$374,072.16View SEC Filing  
12/10/2013John WeilandCOOSell10,389$137.30$1,426,409.70View SEC Filing  
12/10/2013Timothy RingCEOSell15,623$137.12$2,142,225.76View SEC Filing  
12/2/2013Timothy RingCEOSell10,231$138.85$1,420,574.35View SEC Filing  
11/6/2013David BarrettDirectorSell1,600$138.13$221,008.00View SEC Filing  
10/28/2013Herbert L HenkelDirectorSell2,400$134.66$323,184.00View SEC Filing  
10/28/2013Sharon M AlterioVPSell14,002$134.91$1,889,009.82View SEC Filing  
10/23/2013John H WeilandCOOSell60,210$134.01$8,068,742.10View SEC Filing  
10/21/2013John H WeilandCOOSell84,525$125.62$10,618,030.50View SEC Filing  
10/21/2013Timothy M RingCEOSell8,313$125.52$1,043,447.76View SEC Filing  
10/18/2013Gary D DolchVPSell10,000$125.00$1,250,000.00View SEC Filing  
9/24/2013Timothy RingCEOSell8,313$117.77$979,022.01View SEC Filing  
9/9/2013John A DefordVPSell28,364$117.89$3,343,831.96View SEC Filing  
9/3/2013Timothy RingCEOSell10,231$114.65$1,172,984.15View SEC Filing  
8/30/2013Jim BeasleyInsiderSell1,420$115.33$163,768.60View SEC Filing  
8/21/2013Timothy RingCEOSell8,313$113.24$941,364.12View SEC Filing  
8/12/2013Sharon AlterioVPSell13,379$117.01$1,565,476.79View SEC Filing  
8/5/2013Brian P KellyVPSell28,000$115.69$3,239,320.00View SEC Filing  
8/2/2013David M BarrettDirectorSell1,200$115.70$138,840.00View SEC Filing  
8/2/2013Frank Lupisella JrVPSell10,500$115.61$1,213,905.00View SEC Filing  
8/1/2013John H WeilandCOOSell87,336$115.35$10,074,207.60View SEC Filing  
7/29/2013Timothy P CollinsInsiderSell22,025$113.60$2,502,040.00View SEC Filing  
7/26/2013Anthony WeltersDirectorSell5,600$113.12$633,472.00View SEC Filing  
7/26/2013Jean F HollowayVPSell2,275$113.52$258,258.00View SEC Filing  
7/22/2013Timothy M RingCEOSell8,312$113.58$944,076.96View SEC Filing  
6/21/2013Timothy M RingCEOSell8,312$110.05$914,735.60View SEC Filing  
6/20/2013Gary D DolchVPSell14,569$109.97$1,602,152.93View SEC Filing  
5/21/2013Timothy M RingCEOSell8,312$106.65$886,474.80View SEC Filing  
5/20/2013Marc C BreslawskyDirectorSell2,400$107.20$257,280.00View SEC Filing  
5/8/2013Timothy M RingCEOSell8,312$102.00$847,824.00View SEC Filing  
4/11/2013G Mason MorfitInsiderSell300,000$102.47$30,741,000.00View SEC Filing  
4/9/2013Timothy M RingCEOSell8,312$102.00$847,824.00View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for C.R. Bard (NYSE:BCR)
Latest Headlines for C.R. Bard (NYSE:BCR)
Loading headlines, please wait.



C.R. Bard (BCR) Chart for Monday, October, 23, 2017

This page was last updated on 10/23/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.